Investopedia • yesterday
Pfizer is planning to exit the Brazilian market as it puts its generic drug joint venture stake up for sale. Teva and Mylan are possible bidders for the asset.
TheStreet.com • 2 days ago
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
Market Realist • 2 days ago
US corporates dominated the primary market for high-grade bonds in the week ending July 22—making up 52.8% or $16.0 billion of all the issues.
Reuters • 3 days ago
Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said ...
Associated Press • 3 days ago
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after ...
The Wall Street Journal • 3 days ago
Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC’s generics business, conditioned upon Teva’s divestiture of ...
American City Business Journals • 3 days ago
The Federal Trade Commission on Wednesday gave its approval to Teva Pharmaceutical Industries Ltd.’s proposed $40.5B acquisition of Allergan’s generics business. The approval was granted after Teva agreed to divest more than 75 generic drugs to rival businesses — marking the largest drug divestiture order in an FTC pharmaceutical merger case. “Millions of Americans rely daily on generic drugs to treat a wide range of illnesses,” said Debbie Feinstein, director of the FTC’s Bureau of Competition.
Bloomberg • 3 days ago
The U.S. Federal Trade Commission approved Teva Pharmaceutical Industries Ltd.’s $40.5 billion purchase of Allergan Plc’s generic drug-making unit after the companies agreed to the biggest divestiture ...
Bloomberg • 3 days ago
The U.S. Federal Trade Commission approved Teva Pharmaceutical Industries Ltd.’s $40.5 billion purchase of Allergan Plc’s generic drug-making unit after the companies agreed to divest certain drugs to ...
Bloomberg Video • 2 days ago
July 28 -- The U.S. Federal Trade Commission is close to signing off on Teva Pharmaceutical's deal to buy Allergan Plc's generics unit for $40.5 billion according to people familiar with the matter. Bloomberg's Elliot Gotkine reports on "Bloomberg Markets Middle East."
Teva Pharmaceutical Industries LimitedNYSE
After hours: 53.570.07 (0.13%) as of 5:45 PM EDT
|Bid||53.61 x 100|
|Ask||53.74 x 100|
|52wk Range||48.01 - 71.68|
|Day's Range||53.33 - 54.83|
|Avg Vol (3m)||6,179,404|
As of 4:00 PM EDT. Market closed.